Kozlovskaya, L. I., Piniaeva, A. N., Ignatyev, G. M., Gordeychuk, I. V., Volok, V. P., Rogova, Y. V., Shishova, A. A., Kovpak, A. A., Ivin, Y. Y., Antonova, L. P., Mefyod, K. M., Prokosheva, L. S., Sibirkina, A. S., Tarasova, Y. Y., Bayurova, E. O., Gancharova, O. S., Illarionova, V. V., Glukhov, G. S., Sokolova, O. S., Shaitan, K. V., Moysenovich, A. M., Gulyaev, S. A., Gulyaeva, T. V., Moroz, A. V., Gmyl, L. V., Ipatova, E. G., Kirpichnikov, M. P., Egorov, A. M., Siniugina, A. A., & Ishmukhametov, A. A. (2021). long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerging microbes & infections, 10(1), 1790–1806. http://access.bl.uk/ark:/81055/vdc_100140626276.0x000003